Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Elanco revenue
Elanco's revenue is $4.4 billion.
What is Elanco's revenue?
- Elanco's revenue growth from 2017 to 2024 is 53.65%.
- Elanco has 10,200 employees, and the revenue per employee ratio is $435,196.
- Elanco's peak quarterly revenue was $1.3B in 2021(q2).
- Elanco peak revenue was $4.8B in 2021.
- Elanco annual revenue for 2023 was 4.4B, 0.14% growth from 2022.
- Elanco annual revenue for 2024 was 4.4B, 0.5% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Elanco historical revenue
Elanco's peak revenue was $4.8B in 2021. The peak quarterly revenue was $1.3B in 2021(q2).
Elanco's revenue increased from $2.9b in 2017 to $4.4B currently. That's a 53.65% change in annual revenue.
Elanco annual revenue
Elanco annual revenue over time
| Fiscal year / year | Elanco revenue |
|---|---|
| 2017 | $2.9B |
| 2018 | $3.1B |
| 2019 | $3.1B |
| 2020 | $3.3B |
| 2021 | $4.8B |
| 2022 | $4.4B |
| 2023 | $4.4B |
| 2024 | $4.4B |
Rate Elanco's financial transparency
Elanco annual growth
Elanco saw the greatest revenue growth in 2021, when revenue increased by 45.64%.
Elanco had the lowest revenue growth in 2022, when revenue changed by -7.41%.
Elanco annual growth rate over time
| Year | Elanco growth |
|---|---|
| 2018 | 6%↑ |
| 2019 | 0%↑ |
| 2020 | 7%↑ |
| 2021 | 46%↑ |
| 2022 | -7%↓ |
| 2023 | 0%↑ |
| 2024 | 0%↑ |
Elanco quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Elanco quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | $761.1M | $799.3M |
| 2019 | $731.1M | $781.6M | $771.3M | $787.0M |
| 2020 | $658.0M | $586.0M | $890.0M | $1.1B |
| 2021 | $1.2B | $1.3B | $1.1B | $1.1B |
| 2022 | $1.2B | $1.2B | $1.0B | $985.0M |
| 2023 | $1.3B | $1.1B | $1.1B | $1.0B |
| 2024 | $1.2B | $1.2B | $1.0B | $1.0B |
Elanco jobs nearby
Do you work at Elanco?
Did Elanco meet its revenue projections?
Elanco financial information
| CEO | Jeffrey N. Simmons |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 10,200 |
| Date Founded | 1954 |
| Headquarters | Greenfield, Indiana |
| Number of Locations | 5 |
| Revenue | $4.4B |
| Net Income | -$78,000,000 |
| Gross Proft | $2.4B (2024) |
| EBITDA | $1.3B (2024) |
| Tax Rate | 0.3% |
| Total Assets | $15,491,000,000 |
| Ticker | ELAN |
Elanco jobs you might like
Elanco financing
Elanco received early financing of $2.9M on 2017-05-24.
| Series | Round size | Date |
|---|---|---|
| Grant | $2.9M | 05/2017 |
Elanco competitors
Elanco's top competitor, Merck, earned an annual revenue of $64.2B.
Elanco's smallest competitor is BASi with revenue of $23.5M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Zoetis | $87,092 | $9.3B | 11,300 | 211 |
| Merck | $90,328 | $64.2B | 74,000 | 1,473 |
| Warner Chilcott | $92,301 | $105.1M | 3,000 | - |
| Sun Pharmaceutical Industries Inc. | $72,061 | $4.2B | 32,000 | 111 |
| Roche Holding AG | $57,325 | $61.0B | 94,442 | 186 |
| Watson Pharma Pvt Ltd | $79,372 | $5.9B | 21,600 | - |
| West-Ward Pharmaceuticals | $59,065 | $150.0M | 249 | 59 |
| Mallinckrodt | $61,563 | $1.0B | 3,400 | 70 |
| Mylan | $66,113 | $11.5B | 35,000 | 4 |
| Paddock Laboratories | $69,519 | $100.5M | 51 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Elanco highest paying jobs
Zippia gives an in-depth look into the details of Elanco, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Elanco. The employee data is based on information from people who have self-reported their past or current employments at Elanco. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Elanco. The data presented on this page does not represent the view of Elanco and its employees or that of Zippia.
Elanco may also be known as or be related to Elanco, Elanco Animal Health and Elanco Animal Health Incorporated.